Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Hemosol (HML.TO)

Hemosol (HML.TO)

0.00
-0.00 (0.00%)
0 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Hemosol(HML.TO)

Sep 04, 2001
Phase 3 stage required restructuring so competitors now have a year's head start.
Photo of Richard StoneRichard StoneUnlock Rating
$5.05

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Aug 31, 2001
Biotechs can have a drop if the core product doesn't work out. Speculative.
Photo of David BaskinDavid BaskinUnlock Rating
$5.46

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Hemosol(HML.TO)

Aug 24, 2001
Will be 6/9 months before getting approval. Good price.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$6.35

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Aug 16, 2001
Not sure there will be the demand for a blood substitute. Can/will clients change their systems to accommodate?
Photo of Mark Jackson, CFAMark Jackson, CFAUnlock Rating
$7.20

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Hemosol(HML.TO)

Aug 15, 2001
FDA has delayed. Expect them to back on track in 6/9 months. Good price.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$7.35

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Hemosol(HML.TO)

Aug 14, 2001
FDA knocked them back. Look for signs that they are getting back to basics and they revise their applications.
Photo of Robert FloydRobert FloydUnlock Rating
$6.60

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Hemosol(HML.TO)

Aug 03, 2001
Still waiting to get approval. Should be good.
Photo of Brendan CaldwellBrendan CaldwellUnlock Rating
$11.50

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Aug 01, 2001
Should get product approved, but not sure that demand will be strong. Also has competition.
Photo of Bruce CooperBruce CooperUnlock Rating
$12.32

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Hemosol(HML.TO)

Jun 22, 2001
Having problems getting distribution/approvals.
Photo of David DriscollDavid DriscollUnlock Rating
$13.20

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Jun 07, 2001
Will be a market for the product, but has competition and not sure how big the market will be.
Photo of Bruce CooperBruce CooperUnlock Rating
$14.95

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Jun 06, 2001
Preliminary approval in Canada & Europe and in final phase in US. Expensive treatment. Covered by government/health ins. ?
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$14.85

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

May 25, 2001
Better to own it through MDS
Photo of John ZechnerJohn ZechnerUnlock Rating
$15.90

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

May 24, 2001
Good products in final phase, but a one trick pony.
Photo of David DriscollDavid DriscollUnlock Rating
$16.15

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Hemosol(HML.TO)

Apr 18, 2001
Still waiting approval. Once that happens, stock should move up.
Photo of Ed HoEd HoUnlock Rating
$14.00

Stock price when the opinion was issued

biotechnologypharmaceutical
STRONG BUY

Hemosol(HML.TO)

Mar 27, 2001
Got US financing. Getting US attention now (analyst has $18US) Look for new partner announcements in Europe.
Photo of Pier DonniniPier DonniniUnlock Rating
$14.35

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 46 to 60 of 78 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video